More than 5,000 shelved drug candidates were discontinued for business reasons, not safety ones. A new push aims to match ...

West Virginians are paying a heavy price for Big Pharma’s greed. With the cost of medicines squeezing already-tight public budgets and placing intolerable pressure on low-income families, lawmakers ca ...

The company's ability to hold off generic competitors long enough to develop a pair of replacement drugs for Humira that are ...

Add Yahoo as a preferred source to see more of our stories on Google. For decades, the pharmaceutical industry has defended sky-high drug prices by pointing to the high costs of research and ...

Pregnant woman Image by Canva; Tylenol Image by Andy Dean PhotographyShutterstock Texas Attorney General Ken Paxton is suing the makers of Tylenol, Johnson & Johnson, and its spinoff Kenvue, over the ...

The major pharmas are loaded up with trillions in firepower—but are sticking to mid-cap deals. One expert says it might be ...

Novartis (NYSE: NVS) is a major Swiss drug company with a market capitalization of over $300 billion. Its focus areas are extensive, spanning oncology, immunology, neuroscience, respiratory care, and ...

Pharmacist backs Hawley’s PBM crackdown, says big insurers and their pharmacy benefit managers, not Big Pharma, are driving ...

The FTC is monitoring the pharma industry for potential anticompetitive practices, as some of the blockbuster drugs near patent cliffs, an official says. Read more here.

But those Big Pharma executives – many of whom destroyed our lives with the opioid crisis and during COVID – really don’t like giving out those discounts, so they’re trying to dismantle 340B.

For decades, the pharmaceutical industry has defended sky-high drug prices by pointing to the high costs of research and development. But the real story reveals something else entirely. A closer look ...